Literature DB >> 22907292

Peripheral neuropathies in rheumatic disease--a guide to diagnosis.

Jean-Michel Vallat1, Magalie Rabin, Laurent Magy.   

Abstract

Peripheral neuropathy is a common neurological disorder that can be associated with a wide range of conditions, including rheumatic disease. Although the association of the two disorders can be coincidental, an underlying pathogenic link can occur in many instances, which can affect treatment options. The presentation of peripheral neuropathy can be multifaceted, an important consideration when recognizing the condition and optimizing diagnosis. Furthermore, understanding the diagnostic strategy will help physicians treating patients with rheumatic disease who develop peripheral neuropathy. Finally, although available treatment options have greatly reduced the risk of patients with inflammatory disorders developing systemic complications, among which includes peripheral neuropathy, new therapeutic agents can trigger toxic or immune-mediated neuropathies and treatment will need to be adjusted accordingly. In this Review, we will discuss the general approach for diagnosing patients with peripheral neuropathy, and detail the presentation, pathophysiological features and general rules of treatment of patients with peripheral neuropathy in the context of rheumatic disease.

Entities:  

Mesh:

Year:  2012        PMID: 22907292     DOI: 10.1038/nrrheum.2012.138

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  105 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.

Authors:  G Lauria; S T Hsieh; O Johansson; W R Kennedy; J M Leger; S I Mellgren; M Nolano; I S J Merkies; M Polydefkis; A G Smith; C Sommer; J Valls-Solé
Journal:  Eur J Neurol       Date:  2010-07       Impact factor: 6.089

2.  Non-length dependent small fiber neuropathy. a prospective case series.

Authors:  Franco Gemignani; Michela Giovanelli; Francesca Vitetta; Daniele Santilli; Maria F Bellanova; Francesca Brindani; Adriana Marbini
Journal:  J Peripher Nerv Syst       Date:  2010-03       Impact factor: 3.494

Review 3.  Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition.

Authors:  Jean-Michel Vallat; Claudia Sommer; Laurent Magy
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 4.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.

Authors:  Loïc Guillevin; Alfred Mahr; Patrice Callard; Pascal Godmer; Christian Pagnoux; Emmanuelle Leray; Pascal Cohen
Journal:  Medicine (Baltimore)       Date:  2005-09       Impact factor: 1.889

6.  Peripheral neuropathy in patients with systemic lupus erythematosus.

Authors:  Brandusa Florica; Ellie Aghdassi; Jiandong Su; Dafna D Gladman; Murray B Urowitz; Paul R Fortin
Journal:  Semin Arthritis Rheum       Date:  2011-10       Impact factor: 5.532

7.  Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

Authors:  Didier Bouhassira; Nadine Attal; Haiel Alchaar; François Boureau; Bruno Brochet; Jean Bruxelle; Gérard Cunin; Jacques Fermanian; Patrick Ginies; Aurélie Grun-Overdyking; Hélène Jafari-Schluep; Michel Lantéri-Minet; Bernard Laurent; Gérard Mick; Alain Serrie; Dominique Valade; Eric Vicaut
Journal:  Pain       Date:  2005-01-26       Impact factor: 6.961

8.  Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists.

Authors:  Amer Alshekhlee; Kevian Basiri; J Douglas Miles; Saef A Ahmad; Bashar Katirji
Journal:  Muscle Nerve       Date:  2010-05       Impact factor: 3.217

Review 9.  Current status of leprosy: epidemiology, basic science and clinical perspectives.

Authors:  Koichi Suzuki; Takeshi Akama; Akira Kawashima; Aya Yoshihara; Rie R Yotsu; Norihisa Ishii
Journal:  J Dermatol       Date:  2011-10-04       Impact factor: 4.005

Review 10.  Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.

Authors:  Nicola Alcorn; Sarah Saunders; Rajan Madhok
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

View more
  2 in total

Review 1.  Bilateral facial paralysis as a rare neurological manifestation of primary Sjögren's syndrome: case-based review.

Authors:  Zhang Wei; Shi Jiaying; Guo Junhong
Journal:  Rheumatol Int       Date:  2019-06-07       Impact factor: 2.631

Review 2.  Advances in imaging technologies for the assessment of peripheral neuropathies in rheumatoid arthritis.

Authors:  Josefina Gutiérrez; Hugo Sandoval; Iván Pérez-Neri; Antonio Arauz; Juan Carlos López-Hernández; Carlos Pineda
Journal:  Rheumatol Int       Date:  2021-01-11       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.